The capability of SHP2 to mediate signal transduction in several inflammatory pathways, often activated by cytokines and kinases, is also noteworthy, since it highlights the implication of this PTP in various inflammatory diseases, including cancer-related inflammation, neurodegenerative and metabolic disorders [58]. This evidence concerns the gene PTPN11 and cancer.